Ashwagandha Research Overview (also known as Withania somnifera, Indian Ginseng, Winter Cherry, Ajagandha, Kanaje Hindi)
Ashwagandha (Withania somnifera) is an adaptogenic herb whose principal studied compounds are withanolides, steroidal lactones that may influence stress, inflammation, and neuroendocrine signaling. Clinical trials suggest that standardized extracts can reduce perceived stress and cortisol and may support testosterone, sleep, and aspects of performance, although effects vary by population and formulation. KSM-66 is primarily a high-concentration root extract commonly standardized to about 5% withanolides, whereas Sensoril is a root-and-leaf extract commonly standardized to about 10% withanolides and is often used at a lower dose.
For broader research context on nootropic compounds, including comparative stacks, cycling considerations, and interaction notes, see the Complete Nootropic Cheat Sheet.
What Is Ashwagandha?
Ashwagandha is the common name for Withania somnifera, a shrub in the Solanaceae family that is native to India, parts of Africa, and the Middle East and is now cultivated in several regions. Its roots and, in some commercial preparations, leaves contain withanolides, a family of naturally occurring steroidal lactones that includes withaferin A and related compounds. The plant is also known as Indian ginseng, winter cherry, and by several regional names. In Ayurveda, the root has traditionally been classified as a rasayana, or rejuvenating botanical intended to support vitality, resilience, recovery, and healthy aging. Historical use is often described as extending for more than 3,000 years, although traditional use does not by itself establish efficacy for a modern clinical endpoint.
Modern supplement research generally classifies ashwagandha as an adaptogen: a botanical proposed to help the body maintain or regain physiological balance during stress. This classification is functional rather than a formal drug indication. Human studies have examined standardized extracts for perceived stress, salivary or serum cortisol, sleep, anxiety symptoms, resistance training, male reproductive measures, cognition, and thyroid-related outcomes. Results are promising but not uniform; they depend on the extract, dose, duration, baseline health, outcome measure, and quality of the trial. KSM-66 and Sensoril are branded extracts with different plant parts, extraction methods, and standardization profiles, so milligram doses should not be assumed to be interchangeable.
Research Indications
Stress & Anxiety
Perceived stress reduction
Randomized trials of standardized root extracts have reported lower perceived-stress scores versus placebo over approximately 8 weeks.
Cortisol measures
Several studies report reductions in serum cortisol among chronically stressed adults; assay methods and populations differ between trials.
Sleep-related anxiety
Improvements in anxiety-associated sleep complaints have been observed, although effects cannot be separated fully from general stress improvement.
Sleep & Recovery
Sleep quality
Clinical studies using root extract report modest improvements in sleep quality and sleep-onset measures, particularly in participants with insomnia symptoms.
Exercise recovery context
Resistance-training research has associated supplementation with changes in strength and body-composition outcomes; training, diet, and baseline status are important confounders.
Cognition & Mood
Attention and executive function
Small controlled trials suggest possible benefits for select cognitive test outcomes, but replication in larger independent samples is needed.
Mood measures
Mood-related findings are generally secondary outcomes and remain insufficient to establish an antidepressant effect.
Metabolic & Hormonal Outcomes
Male reproductive parameters
Some studies in specific male populations report changes in testosterone or semen parameters; these findings should not be generalized to all users.
Glucose and lipid markers
Early trials and reviews suggest potential metabolic effects, but heterogeneity and limited study quality preclude firm conclusions.
Research Protocols
As reported in cited literature and research-community logs (see Research Citations below) — not a personal dosing recommendation.
| Research Application | Dose | Frequency | Route |
|---|
| General stress support | 240–300 mg standardized root extract | Once daily | Oral |
| Stress and anxiety trials | 300 mg standardized root extract | Twice daily | Oral |
| Sleep-focused studies | 120–300 mg extract | Once daily, evening | Oral |
| Resistance-training research | 300 mg standardized root extract | Twice daily | Oral |
Timing
Studies commonly administer standardized extracts with meals for 6–12 weeks. Evening dosing may be preferable if drowsiness occurs; move dosing earlier or discontinue if it disrupts sleep or causes gastrointestinal discomfort.
Peptide Interactions
Often co-used for sleep or stress support; overlapping sedating effects may occur in sensitive individuals.
May be paired in stress-management protocols, although direct combination trials are limited.
No established pharmacologic conflict is known; both have appeared in exercise-oriented supplement routines.
Concurrent use may increase drowsiness, impaired coordination, or other central nervous system depressant effects.
Ashwagandha may affect thyroid laboratory values or thyroid activity; use only with clinician oversight when taking thyroid medication.
Potential immunomodulatory activity creates a theoretical concern for people receiving immunosuppressive therapy.
Reported Research Timeline
01Days 1–3 (reported in cited studies): some users notice mild relaxation, sleepiness, or gastrointestinal effects; many notice no immediate change.
02Week 1–2 (reported in cited studies): tolerability is typically the main observation period; take note of sleep changes, digestive symptoms, and daytime alertness.
03Weeks 3–4 (reported in cited studies): changes in perceived stress, evening wind-down, or sleep quality may become more apparent if a response occurs.
04Weeks 6–8 (reported in cited studies): this is the duration used in several stress and sleep trials; compare outcomes with baseline rather than day-to-day fluctuations.
05Weeks 8–12 (reported in cited studies): reassess benefit, adverse effects, medications, and continued need with a healthcare professional rather than escalating dose automatically.
Safety Notes
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
Use a standardized product and begin with the lowest studied amount to assess individual tolerance.
Reported adverse effects can include stomach upset, loose stools, nausea, headache, and drowsiness.
Avoid use during pregnancy; discuss breastfeeding use with a qualified clinician because safety data are inadequate.
Consult a clinician before use with thyroid disease, autoimmune disease, diabetes, low blood pressure, or active liver disease.
Stop before surgery unless the surgical team advises otherwise, especially when sedating medications or anesthesia are anticipated.
Seek Medical Attention If:
You develop yellowing of the skin or eyes, dark urine, severe fatigue, persistent nausea, or upper abdominal pain, which may signal liver injury.
You experience facial swelling, hives, wheezing, or difficulty breathing after use.
You develop marked palpitations, tremor, agitation, heat intolerance, or other symptoms consistent with excessive thyroid activity.
Quality Indicators
Verified Marker
Batch-specific certificate of analysis
Look for a current lot-specific COA identifying the botanical material and reporting assay results rather than a generic certificate.
Verified Marker
Withanolide assay and extract specification
A quality label states root versus root-and-leaf material, extract ratio where applicable, and standardized withanolide content.
Verified Marker
Independent contaminant testing
Third-party testing should cover heavy metals and microbiological contaminants; pesticide screening is also desirable for botanical products.
Acceptable Range
Accurate capsule and serving disclosure
The label clearly distinguishes extract milligrams from raw herb powder and gives the amount per capsule and per daily serving.
Quality Concern
Proprietary blend or unverifiable potency claim
Avoid products that conceal ingredient amounts, omit botanical part and standardization details, or provide no accessible testing documentation.
Research Citations
- A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of Ashwagandha root in reducing stress and anxiety in adults.
Chandrasekhar, K., Kapoor, J., & Anishetty, S., 2012, Indian Journal of Psychological Medicine - An investigation into the stress-relieving and pharmacological actions of an ashwagandha extract: A randomized, double-blind, placebo-controlled study.
Lopresti, A. L., Smith, S. J., Malvi, H., & Kodgule, R., 2019, Medicine - Examining the effect of Withania somnifera supplementation on muscle strength and recovery: A randomized controlled trial.
Wankhede, S., Langade, D., Joshi, K., Sinha, S. R., & Bhattacharyya, S., 2015, Journal of the International Society of Sports Nutrition - Exploratory study to evaluate tolerability, safety, and activity of Ashwagandha (Withania somnifera) in healthy volunteers.
Raut, A. A., Rege, N. N., Tadvi, F. M., et al., 2012, Indian Journal of Psychological Medicine - Efficacy and safety of Ashwagandha root extract in insomnia and anxiety: A double-blind, randomized, placebo-controlled study.
Langade, D., Kanchi, S., Salve, J., Debnath, K., & Ambegaokar, D., 2019, Cureus
Research Focus
cortisol reduction, stress adaptation, testosterone support, thyroid function, athletic performance, cognitive enhancement, withanolides
Frequently Asked Questions
What should researchers watch for with Ashwagandha?
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
What should researchers expect over time with Ashwagandha?
Days 1–3 (reported in cited studies): some users notice mild relaxation, sleepiness, or gastrointestinal effects; many notice no immediate change.
How is Ashwagandha typically administered in research?
As reported in cited literature and research-community logs (see Research Citations below) — not a personal dosing recommendation.
Browse all peptides in the Encyclopedia →